AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Ofloxacine in South Africa
9 products registered with SAHPRA — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TAFLOC 400 mg | 35/20.1.1/0175 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| ZANOCIN 200 TABLETS | 34/20.1.1/0209 | Unimed Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| ZANOCIN 400 TABLETS | 34/20.1.1/0210 | Unimed Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| OFLOXACIN 200 mg AUSTELL | A39/20.1.1/0149 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| OFLOXACIN 400 mg AUSTELL | A39/20.1.1/0150 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| EXOCIN | Z/15.1/347 | Abbvie (Pty) Ltd | active | 1 Jan 1900 |
| ADCO-OFLOXACIN 200 mg | 34/20.1.1/0211 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
| ADCO-OFLOXACIN 400 mg | 34/20.1.1/0212 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
| TAFLOC 200 mg | 35/20.1.1/0174 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
Ofloxacine — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Ofloxacine, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Ofloxacine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.